These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1136 related items for PubMed ID: 1719267
21. Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: A Pediatric Intergroup Study--Pediatric Oncology Group 9048 and Children's Cancer Group 8891. Rogers PC, Olson TA, Cullen JW, Billmire DF, Marina N, Rescorla F, Davis MM, London WB, Lauer SJ, Giller RH, Cushing B, Pediatric Oncology Group 9048, Children's Cancer Group 8891. J Clin Oncol; 2004 Sep 01; 22(17):3563-9. PubMed ID: 15337806 [Abstract] [Full Text] [Related]
22. [Therapy of testicular germ cell tumors. Current status of the MAHO studies]. Haas RJ, Schmidt P, Göbel U, Harms D. Klin Padiatr; 1993 Sep 01; 205(4):225-30. PubMed ID: 8397320 [Abstract] [Full Text] [Related]
23. Paclitaxel+BEP (T-BEP) regimen as induction chemotherapy in poor prognosis patients with nonseminomatous germ cell tumors: a phase II study. Tryakin A, Fedyanin M, Kanagavel D, Fainstein I, Sergeev J, Polockij B, Matveev V, Zakharova T, Garin A, Tjulandin S. Urology; 2011 Sep 01; 78(3):620-5. PubMed ID: 21764427 [Abstract] [Full Text] [Related]
24. Amifostine does not protect against the ototoxicity of high-dose cisplatin combined with etoposide and bleomycin in pediatric germ-cell tumors: a Children's Oncology Group study. Marina N, Chang KW, Malogolowkin M, London WB, Frazier AL, Womer RB, Rescorla F, Billmire DF, Davis MM, Perlman EJ, Giller R, Lauer SJ, Olson TA, Children's Oncology Group. Cancer; 2005 Aug 15; 104(4):841-7. PubMed ID: 15999362 [Abstract] [Full Text] [Related]
25. Paclitaxel, bleomycin, etoposide, and cisplatin (T-BEP) as initial treatment in patients with poor-prognosis germ cell tumors (GCT): a phase II study. Mardiak J, Sálek T, Sycová-Milá Z, Obertová J, Recková M, Mego M, Hlavatá Z, Brozmanová K, Risnyovzská Z, Svetlovská D, Koza I. Neoplasma; 2007 Aug 15; 54(3):240-5. PubMed ID: 17447857 [Abstract] [Full Text] [Related]
26. High-dose chemotherapy with autologous stem cell support in patients with metastatic non-seminomatous testicular cancer - a report from the Swedish Norwegian Testicular Cancer Group (SWENOTECA). Haugnes HS, Laurell A, Stierner U, Bremnes RM, Dahl O, Cavallin-Ståhl E, Cohn-Cedermark G. Acta Oncol; 2012 Feb 15; 51(2):168-76. PubMed ID: 22175254 [Abstract] [Full Text] [Related]
28. Testicular germ cell tumors, an update. Results of the German cooperative studies 1982-1997. Haas RJ, Schmidt P, Göbel U, Harms D. Klin Padiatr; 1999 Feb 15; 211(4):300-4. PubMed ID: 10472566 [Abstract] [Full Text] [Related]
29. Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group. Albers P, Siener R, Krege S, Schmelz HU, Dieckmann KP, Heidenreich A, Kwasny P, Pechoel M, Lehmann J, Kliesch S, Köhrmann KU, Fimmers R, Weissbach L, Loy V, Wittekind C, Hartmann M, German Testicular Cancer Study Group. J Clin Oncol; 2008 Jun 20; 26(18):2966-72. PubMed ID: 18458040 [Abstract] [Full Text] [Related]
30. The effect of cisplatin dose and surgical resection in children with malignant germ cell tumors at the sacrococcygeal region: a pediatric intergroup trial (POG 9049/CCG 8882). Rescorla F, Billmire D, Stolar C, Vinocur C, Colombani P, Cullen J, Giller R, Cushing B, Lauer S, Davis M, Hawkins E, Shuster J, Krailo M. J Pediatr Surg; 2001 Jan 20; 36(1):12-7. PubMed ID: 11150431 [Abstract] [Full Text] [Related]
31. Malignant mediastinal germ cell tumors: an intergroup study. Billmire D, Vinocur C, Rescorla F, Colombani P, Cushing B, Hawkins E, London WB, Giller R, Lauer S. J Pediatr Surg; 2001 Jan 20; 36(1):18-24. PubMed ID: 11150432 [Abstract] [Full Text] [Related]
32. [The prognostic significance of serum alpha 1-fetoprotein in children and adolescents with malignant extracranial non-testicular germ cell tumors]. Calaminus G, Vesterling-Hörner D, Bökkerink JP, Gadner H, Günther G, Haas HJ, Jürgens H, Teske C, Göbel U. Klin Padiatr; 1991 Jan 20; 203(4):246-50. PubMed ID: 1719268 [Abstract] [Full Text] [Related]
33. Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: the SWENOTECA management program. Tandstad T, Dahl O, Cohn-Cedermark G, Cavallin-Stahl E, Stierner U, Solberg A, Langberg C, Bremnes RM, Laurell A, Wijkstrøm H, Klepp O. J Clin Oncol; 2009 May 01; 27(13):2122-8. PubMed ID: 19307506 [Abstract] [Full Text] [Related]
38. [BEP (bleomycin, etoposide, cisplatinum) chemotherapy as an induction therapy of advanced extragonadal germ cell tumor]. Goto S, Fukui I, Ando M, Kihara K, Kitahara S, Tsujii T, Noro A, Hagiwara T, Toyoshima T, Tsukamoto T. Hinyokika Kiyo; 1991 Dec 01; 37(12):1689-93. PubMed ID: 1723842 [Abstract] [Full Text] [Related]
39. Combination chemotherapy in malignant non-seminomatous germ-cell tumors: results of a cooperative study of the German Society of Pediatric Oncology (MAKEI 83). Gobel U, Calaminus G, Häas RJ, Jurgens H, Niethammer D, Ritter J, Spaar HJ, Harms D. Cancer Chemother Pharmacol; 1989 Dec 01; 24 Suppl 1():S34-9. PubMed ID: 2547530 [Abstract] [Full Text] [Related]
40. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues. Ulbright TM. Mod Pathol; 2005 Feb 01; 18 Suppl 2():S61-79. PubMed ID: 15761467 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]